Fibrolamellar Carcinoma
generalA distinctive type of liver cell carcinoma that arises in non-cirrhotic livers and is seen predominantly in young patients. The tumor cells are polygonal and deeply eosinophilic, and are embedded in a fibrous stroma. The prognosis is similar to classical hepatocellular carcinoma that arises in non-cirrhotic livers, and better than hepatocellular carcinoma that arises in cirrhotic livers.
59
Centers
83
Active Trials
$7M
Cancer Funding
Specific Cancer Types(2)
Top Centers for Fibrolamellar Carcinoma(59)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive High-Volume Research Center | 71.4 |
| 2 | Boston University Cancer CenterBoston, MA High-Volume Research Center | 71.4 |
| 3 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 68.0 |
| 4 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 68.0 |
| 5 | NCI Comprehensive Active Research Program | 68.0 |
| 6 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 68.0 |
| 7 | NCI Clinical Active Research Program | 68.0 |
| 8 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 68.0 |
| 9 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 68.0 |
| 10 | NCI Comprehensive Active Research Program | 64.0 |
| 11 | NCI Comprehensive Active Research Program | 47.4 |
| 12 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 47.4 |
| 13 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 47.4 |
| 14 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 47.4 |
| 15 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 47.4 |
| 16 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 47.4 |
| 17 | NCI Comprehensive Active Research Program | 47.4 |
| 18 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 47.4 |
| 19 | NCI Comprehensive Active Research Program | 47.4 |
| 20 | NCI Comprehensive Active Research Program | 47.4 |
| 21 | NCI Comprehensive Active Research Program | 47.4 |
| 22 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 47.4 |
| 23 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 47.4 |
| 24 | NCI Comprehensive Active Research Program | 47.4 |
| 25 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 47.4 |
| 26 | UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program | 47.4 |
| 27 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 47.4 |
| 28 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 47.4 |
| 29 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 47.4 |
| 30 | Cedars-Sinai CancerLos Angeles, CA Active Research Program | 47.4 |
| 31 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 47.4 |
| 32 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 47.4 |
| 33 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 47.4 |
| 34 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 47.4 |
| 35 | Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive Active Research Program | 47.4 |
| 36 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 47.4 |
| 37 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 47.4 |
| 38 | University of Illinois Cancer CenterChicago, IL Active Research Program | 47.4 |
| 39 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program | 47.4 |
| 40 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 47.4 |
| 41 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 47.4 |
| 42 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 47.4 |
| 43 | Active Research Program | 47.4 |
| 44 | Cancer Center at IllinoisUrbana, IL Active Research Program | 47.4 |
| 45 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 47.4 |
| 46 | Penn State Cancer InstituteHershey, PA Active Research Program | 47.4 |
| 47 | Livestrong Cancer InstitutesAustin, TX Active Research Program | 47.4 |
| 48 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 47.4 |
| 49 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 47.4 |
| 50 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 47.4 |
| 51 | The University of Vermont Cancer CenterBurlington, VT Active Research Program | 47.4 |
| 52 | Active Research Program | 47.4 |
| 53 | Upstate Cancer CenterSyracuse, NY Active Research Program | 47.4 |
| 54 | Loma Linda University Cancer CenterLoma Linda, CA Active Research Program | 47.4 |
| 55 | Active Research Program | 47.4 |
| 56 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 47.4 |
| 57 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 46.7 |
| 58 | UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive Active Research Program | 46.1 |
| 59 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 45.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →